Avidity Biosciences
ISIN US05370A1088
|WKN A2P5NK
Overview
Description
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Healthcare Biopharmaceuticals Other Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 4,467.79 m |
| EPS, EUR | -2.73 |
| P/B ratio | 3.98 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 8.84 m |
| Net income, EUR | -196.30 m |
| Profit margin | -2,219.87% |
What ETF is Avidity Biosciences in?
There are 16 ETFs which contain Avidity Biosciences. All of these ETFs are listed in the table below. The ETF with the largest weighting of Avidity Biosciences is the Global X Genomics & Biotechnology UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,941 | 0.28% | 7 | +15.13% | A2DWAC | IE00BDGV0746 |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0.39% | Equity World Health Care Social/Environmental Innovation | 98 | 0.30% | 3 | +4.92% | DBX0R2 | IE000KD0BZ68 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,941 | 0.25% | 74 | +18.59% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,474 | 0.45% | 774 | +9.19% | A1W56P | IE00BCBJG560 |
| Global X Genomics & Biotechnology UCITS ETF | 5.18% | Equity World Health Care Biotech | 41 | 0.50% | 5 | -0.97% | A2QRCP | IE00BM8R0N95 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.08% | Equity United States Small Cap | 1,032 | 0.30% | 118 | +10.34% | A0Q8H2 | IE00B3CNHJ55 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.17% | Equity United States Small Cap | 1,499 | 0.30% | 1,165 | +9.54% | A1XEJT | IE00BJZ2DD79 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.01% | Equity United States Multi-Factor Strategy | 1,941 | 0.25% | 30 | +18.24% | A2DND0 | IE00BDGV0308 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,941 | 0.28% | 24 | +13.64% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.08% | Equity United States Small Cap | 1,604 | 0.43% | 1,557 | +8.22% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.41% | Equity United States Health Care Biotech | 215 | 0.35% | 35 | +15.27% | A2JDYM | IE00BDZVHG35 |
| iShares MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,330 | 0.35% | 3,585 | +9.50% | A2DWBY | IE00BF4RFH31 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.41% | Equity United States Health Care Biotech | 215 | 0.35% | 476 | +15.03% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.01% | Equity United States Small Cap | 1,733 | 0.30% | 455 | +10.32% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.06% | Equity World Small Cap | 2,194 | 0.35% | 62 | +8.23% | A3C14G | IE000T9EOCL3 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.17% | Equity United States Small Cap | 1,811 | 0.30% | 2,803 | +9.59% | A1XFN1 | IE00BJ38QD84 |
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99€ | 1000 | View offer* | |
 | 0.00€ | 2500 | View offer* | |
 | 0.00€ | 500 | View offer* | |
 | 0.00€ | 300 | View offer* | |
 | 5.90€ | - | View offer* |
Source: justETF Research; As of 8/2024; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.